Where is Titanovo located?

Titanovo is headquartered in Raleigh, United States.

Who is the current CEO of Titanovo?

Oleksandr Savsunenko of Titanovo.

Where does Titanovo rank among its competitors?

Titanovo ranks 250th amongst 180 active competitors, of which 28 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Genomind, which secured $400K in Feb, 2025.

Who are the top competitors of Titanovo?

Titanovo's top competitors include 23andMe, Helix and Color. Among them, Genomind secured the most recent funding round in February, 2025.

Titanovo - 2026 Company Profile, Team & Competitors

Titanovo is a deadpooled company based in Raleigh (United States), founded in 2015 by Corey McCarren and Oleksandr Savsunenko. It operates as a Direct-to-consumer saliva based tests. The company has 180 active competitors, including 28 funded and 13 that have exited. Its top competitors include companies like 23andMe, Helix and Color.

Company Details

Titanovo offers direct-to-consumer saliva-based tests. The company offers three major tests using multiplex qPCR. The Telomere Length testing kit measures telomere length from the patient's cheek swab sample and correlates it with overall health. The Longevity genotyping panel assays the APOE, ACE, and APOC3 genes as markers for the probability of living up to a 100. Their latest test DNA Lifestyle Coach consists of a fitness panel, diet panel, stress and detox panel, and dental and skin panel. Titanovo previously raised $10K through an Indiegogo campaign and is looking to crowdfund for DNA Lifestyle Coach as well.

Website: titanovo.com
Social

Key Metrics

Founded Year

2015

Location

Raleigh, United States

Stage

Deadpooled

Ranked

250^th among 264 competitors

Similar Companies

MyHeritage & 598 more

View Titanovo's full profile

Titanovo has not raised any funding rounds yet.

The founders of Titanovo are Corey McCarren and Oleksandr Savsunenko.

Here are the details of Titanovo's key team members:

Corey McCarren: Co-Founder & COO of Titanovo.
Oleksandr Savsunenko: Co-Founder & CEO of Titanovo.

View details of Titanovo's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Titanovo include 23andMe, Helix and Color. Here is the list of Top 10 competitors of Titanovo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	23andMe 2006, Sunnyvale (United States), Acquired	Provider of genetic test solutions to study ancestry, genealogy, and inherited traits	$944M	Fidelity Investments, Google Ventures & 35 others	77/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
3rd	Color 2013, Burlingame (United States), Series E	Provider of end-to-end Virtual clinic offering cancer-based solutions	$491M	General Catalyst, T. Rowe Price & 46 others	66/100
4th	Nucleus Genomics 2021, Manhattan (United States), Series A	Provider of genetic testing kits for rare variant analysis	$32M	Founders Fund, Giant Step Capital & 27 others	62/100
5th	MyOme 2017, San Carlos (United States), Series B	Provider of a platform for gene analysis to determine genetic diseases and drug response	$36M	Healthcare Ventures, Foresite Capital & 1 others	60/100
6th	InformedDNA 2007, St Petersburg (United States), Series A	Provider of network of genetics experts to help patients and providers	$19.2M	Frist Cressey Ventures, NovaQuest Capital Management ... & 5 others	57/100
7th	Genomind 2009, King Of Prussia (United States), Series C	Developer of genetic tests for personalised medicines to enhance mental health treatment	$64.4M	Claritas Capital, SVB & 1 others	56/100
8th	Veritas Genetics 2014, Danvers (United States), Acquired	Provider of genetic testing products	$53.4M	Trustbridge Partners, Simcere Pharma & 6 others	55/100
9th	Segterra (InsideTracker) 2009, Cambridge (United States), Series B	Personalized path for health, wellness, and performance applications	$17.5M	PeakBridge, BASF & 4 others	54/100
10th	Counsyl 2007, San Francisco (United States), Acquired	DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening	$113M	Perceptive Advisors, Goldman Sachs & 14 others	54/100
250th	Titanovo 2015, Raleigh (United States), Deadpooled	Direct-to-consumer saliva based tests	-	-	15/100